Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023)
Catheter Precision (VTAK) posted quarterly Long-Term Deferred Tax of $26.8 million for Q4 2023, up 207.88% year-over-year from $8.7 million in Q4 2022, and up 207.88% quarter-over-quarter from $8.7 million in Q4 2022.
Catheter Precision (VTAK) Long-Term Deferred Tax (2022 - 2023) Analysis & Trends
Catheter Precision (VTAK) has reported Long-Term Deferred Tax for 2 consecutive years, with $26.8 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Long-Term Deferred Tax rose 207.88% year-over-year to $26.8 million; the TTM figure through Dec 2023 stood at $26.8 million (up 207.88% YoY), while the FY2023 annual figure was $26.8 million, up 207.88% from the prior year.
- Long-Term Deferred Tax climbed to $26.8 million in Q4 2023 per VTAK's latest filing, from $8.7 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $26.8 million in Q4 2023 and bottomed at $8.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Catheter Precision | 575,627.53 | -1.26 Mn | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 26.77 Mn |
| Dec 31, 2022 | 8.69 Mn |